Published in Cell Cycle on November 01, 2007
Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med (2012) 1.99
Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃. Blood (2011) 1.68
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis (2009) 1.58
αV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med (2011) 1.33
Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys (2008) 1.31
Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. PLoS One (2012) 1.05
Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J Biol Chem (2011) 1.04
c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 and by disruption of actin. Blood (2010) 1.02
alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. Am J Pathol (2009) 1.01
The role of extracellular matrix in vascular branching morphogenesis. Cell Adh Migr (2012) 0.93
Unique disulfide bonds in epidermal growth factor (EGF) domains of β3 affect structure and function of αIIbβ3 and αvβ3 integrins in different manner. J Biol Chem (2012) 0.90
Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS One (2012) 0.89
Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. PLoS One (2010) 0.86
Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk. Arterioscler Thromb Vasc Biol (2014) 0.83
Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis. J Pharmacol Exp Ther (2014) 0.83
Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin. Mol Ther (2014) 0.82
Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells. Oncotarget (2016) 0.80
Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk. Cell Death Dis (2015) 0.80
Protective role of osteopontin in endodontic infection. Immunology (2009) 0.80
c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5. PLoS One (2012) 0.80
Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. J Oncol (2011) 0.79
Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential. Toxicon (2011) 0.79
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer. PLoS One (2012) 0.78
Measurement of cationic and intracellular modulation of integrin binding affinity by AFM-based nanorobot. Biophys J (2013) 0.76
Diverse functions of kindlin/fermitin proteins during embryonic development in Xenopus laevis. Mech Dev (2014) 0.76
Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis. Bioeng Transl Med (2017) 0.75
Biological production of an integrin αvβ3 targeting imaging probe and functional verification. Biomed Res Int (2015) 0.75
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors. ChemistryOpen (2015) 0.75
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
Angiogenesis in life, disease and medicine. Nature (2005) 15.36
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
Angiogenesis in health and disease. Nat Med (2003) 14.02
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell (1994) 9.51
Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol (1995) 8.88
The extracellular matrix as a cell survival factor. Mol Biol Cell (1993) 6.32
Definition of two angiogenic pathways by distinct alpha v integrins. Science (1995) 6.00
Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res (2005) 5.08
Ligand binding to integrins. J Biol Chem (2000) 4.94
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med (2002) 4.87
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest (1995) 3.69
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med (2005) 3.60
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev (1999) 3.35
A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell (2000) 3.03
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J (1999) 2.92
Association of insulin receptor substrate-1 with integrins. Science (1994) 2.56
Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J (1997) 2.40
An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci (1995) 2.38
A reevaluation of integrins as regulators of angiogenesis. Nat Med (2002) 2.36
Akt1 in endothelial cell and angiogenesis. Cell Cycle (2006) 2.22
Integrin and growth factor receptor crosstalk. Circ Res (2001) 2.18
Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res (2006) 1.96
Integrin signaling is critical for pathological angiogenesis. J Exp Med (2006) 1.91
Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res (2004) 1.88
Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J Biol Chem (2000) 1.83
The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci (1998) 1.70
Integrins: molecular targets in cancer therapy. Curr Oncol Rep (2006) 1.63
Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium (2006) 1.46
Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? Eur J Nucl Med Mol Imaging (2006) 1.39
Coming to grips with integrin binding to ligands. Curr Opin Cell Biol (2002) 1.38
Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins. Proc Natl Acad Sci U S A (2004) 1.33
Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci (2003) 1.24
Integrin-mediated death: an explanation of the integrin-knockout phenotype? Nat Med (2002) 1.20
Integrin signaling and matrix assembly. Tumour Biol (1996) 1.13
Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths. Curr Opin Cell Biol (1999) 1.11
Endothelial cell-matrix interactions. Microsc Res Tech (2003) 1.09
GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment. Cell Cycle (2007) 1.09
A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas. Cancer Res (2005) 1.08
The Ig-ITIM superfamily member PECAM-1 regulates the "outside-in" signaling properties of integrin alpha(IIb)beta3 in platelets. Blood (2005) 1.05
Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin. J Cell Biol (1998) 1.04
Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler Thromb Vasc Biol (2004) 1.03
Caveolae internalization regulates integrin-dependent signaling pathways. Cell Cycle (2006) 1.03
Endothelial integrins and angiogenesis: not so simple anymore. J Clin Invest (2002) 0.94
Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phase. Cell Cycle (2007) 0.94
Integrin signaling: cytoskeletal complexes, MAP kinase activation, and regulation of gene expression. Cell Adhes Commun (1998) 0.91
Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors. Cancer Metastasis Rev (1999) 0.90
Assembly and patterning of vertebrate blood vessels. Trends Cardiovasc Med (2004) 0.86
alphav Vitronectin receptors in vascular-mediated disorders. Med Res Rev (2003) 0.79
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 5.05
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med (2007) 4.11
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature (2010) 3.70
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med (2005) 3.60
Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res (2007) 2.74
A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med (2009) 2.31
Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood (2004) 2.23
Akt1 in endothelial cell and angiogenesis. Cell Cycle (2006) 2.22
Integrin signaling is critical for pathological angiogenesis. J Exp Med (2006) 1.91
VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci U S A (2005) 1.84
A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood (2011) 1.61
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev (2006) 1.58
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis (2009) 1.58
Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem (2007) 1.52
PAK1 as a therapeutic target. Expert Opin Ther Targets (2010) 1.48
Kindlins in FERM adhesion. Blood (2010) 1.48
Molecular pathway for cancer metastasis to bone. J Biol Chem (2003) 1.47
p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res (2004) 1.47
ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest (2010) 1.45
Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood (2002) 1.44
Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J (2005) 1.34
Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys (2008) 1.31
Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression. J Pharmacol Exp Ther (2010) 1.31
Angiogenesis in melanoma. Semin Oncol (2007) 1.30
Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ Res (2012) 1.24
Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis (2008) 1.20
14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly. J Cell Physiol (2009) 1.19
Oxidative stress in angiogenesis and vascular disease. Blood (2013) 1.19
Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood (2007) 1.19
Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl) (2013) 1.15
Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells. Radiat Res (2010) 1.12
Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol (2003) 1.12
The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. J Cell Biol (2008) 1.11
Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke. PLoS One (2011) 1.10
Antiangiogenic therapy for cancer: an update. Pharmacotherapy (2012) 1.10
PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer. Int J Oncol (2011) 1.09
TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J Cell Physiol (2011) 1.09
Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. Cell Metab (2012) 1.07
P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion. J Biol Chem (2012) 1.07
Methods for isolation of endothelial and smooth muscle cells and in vitro proliferation assays. Methods Mol Med (2006) 1.07
Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Res (2012) 1.06
TGFβ1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases. Biochem Biophys Res Commun (2012) 1.03
Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes (2012) 1.02
Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood (2011) 1.01
Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy (2010) 1.01
Rac1 activation driven by 14-3-3ζ dimerization promotes prostate cancer cell-matrix interactions, motility and transendothelial migration. PLoS One (2012) 1.01
Metastatic properties of prostate cancer cells are controlled by VEGF. Cell Commun Adhes (2004) 0.99
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence. Clin Sci (Lond) (2011) 0.99
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis. BMC Cancer (2012) 0.99
Composition and potential anticancer activities of essential oils obtained from myrrh and frankincense. Oncol Lett (2013) 0.98
Coronary artery disease and the thrombospondin single nucleotide polymorphisms. Int J Biochem Cell Biol (2004) 0.94
Regulation of cell adhesion and migration by Kindlin-3 cleavage by calpain. J Biol Chem (2012) 0.91
Binding and inactivation of the germ cell-specific protein phosphatase PP1gamma2 by sds22 during epididymal sperm maturation. Biol Reprod (2003) 0.91
Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B. J Pharmacol Exp Ther (2014) 0.90
Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS One (2012) 0.89
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo. Oncotarget (2014) 0.89
Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J Cell Physiol (2011) 0.88
Akt1 mediates α-smooth muscle actin expression and myofibroblast differentiation via myocardin and serum response factor. J Biol Chem (2013) 0.88
Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition. Clin Exp Metastasis (2008) 0.88
Integrin function in vascular biology: a view from 2013. Curr Opin Hematol (2014) 0.88
Oxidation as "the stress of life". Aging (Albany NY) (2011) 0.87
Changes in intracellular distribution and activity of protein phosphatase PP1gamma2 and its regulating proteins in spermatozoa lacking AKAP4. Biol Reprod (2004) 0.87
Interference with akt signaling protects against myocardial infarction and death by limiting the consequences of oxidative stress. Sci Signal (2013) 0.86
Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis. J Cell Physiol (2013) 0.85
Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction. J Biol Chem (2004) 0.85
Integrin signaling in vascular function. Curr Opin Hematol (2012) 0.85
Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model. Neoplasia (2010) 0.84
Identification of chloride intracellular channel proteins in spermatozoa. FEBS Lett (2004) 0.83
TNFα induces inflammatory stress response in microvascular endothelial cells via Akt- and P38 MAP kinase-mediated thrombospondin-1 expression. Mol Cell Biochem (2015) 0.81
Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer. Neoplasia (2011) 0.81
alphaB-crystallin: a novel VEGF chaperone. Blood (2010) 0.80
Vascular integrin signaling. Methods Enzymol (2008) 0.80
The dark side of the oxidative force in angiogenesis. Nat Med (2012) 0.78
A novel function for dendritic cell: clearance of VEGF via VEGF receptor-1. Biochem Biophys Res Commun (2009) 0.77
Effects of Borneol on Pharmacokinetics and Tissue Distribution of Notoginsenoside R1 and Ginsenosides Rg1 and Re in Panax notoginseng in Rabbits. J Anal Methods Chem (2013) 0.76
Brain and muscle ARNT-like protein BMAL1 regulates ROS homeostasis and senescence: a possible link to hypoxia-inducible factor-mediated pathway. Cell Cycle (2012) 0.76
Meta-Analysis of Comparison of the Newer P2Y12 Inhibitors (Oral Preparation or Intravenous) to Clopidogrel in Patients with Acute Coronary Syndrome. J Cardiovasc Pharmacol (2016) 0.75
Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery. J Cardiovasc Pharmacol (2015) 0.75
3D compressive spectral integral imaging. Opt Express (2016) 0.75